A5081608100- COVID-19 Clinical Research Studies
- Family Support in Illness
- Palliative Care and End-of-Life Issues
- Pediatric Hepatobiliary Diseases and Treatments
- Thermal Regulation in Medicine
- Long-Term Effects of COVID-19
- Gallbladder and Bile Duct Disorders
- Pancreatic and Hepatic Oncology Research
- Cancer survivorship and care
Azienda Sanitaria Unità Locale di Reggio Emilia
2024
Istituti di Ricovero e Cura a Carattere Scientifico
2022-2024
Rationale Pulse glucocorticoid therapy is used in hyperinflammation related to coronavirus disease 2019 (COVID-19). We evaluated the efficacy and safety of pulse intravenous methylprednisolone addition standard treatment COVID-19 pneumonia. Methods In this multicentre, randomised, double-blind, placebo-controlled trial, 304 hospitalised patients with pneumonia were randomised receive 1 g intravenously for three consecutive days or placebo dexamethasone. The primary outcome was duration...
Background Cancer is a life-threatening disease that triggers not only vulnerability to distressing symptoms but also meaning-making process may lead post-traumatic growth. As people often struggle integrate cancer illness into their meaning system reach an adaptive meaning, psychological interventions focused on reappraisal of the experience can facilitate this process. This multicenter randomized controlled trial (RCT) was primarily aimed at assessing efficacy writing intervention known as...
Background: Post-endoscopic retrograde cholangiopancreatography acute pancreatitis (PEP) is the most common complication of endoscopic (ERCP). Studies have shown that periprocedural administration lactated Ringer's (LR) solution may prevent PEP by multiple mechanisms. To assess evidence for aggressive hydration with LR alone or in combination non-steroidal anti-inflammatory drugs (NSAIDs) as a preventive measure post-ERCP pancreatitis, an updated systematic review was conducted.